CD4 and cervical cancer: In this study, monitoring of cervical cancer patients during cervical cancer therapy showed a decrease in CD4+ T cells in the patients` blood, but a significant increase in Th17 frequencies after aCRT and pCRT in comparison to patients with surgery alone.